Processa Pharmaceuticals, Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| SEC Ref. No. | Title of Document |
| 4.1 | Form of Common Warrant (incorporated by reference to Exhibit 4.1 to Form 8-K filed June 18, 2025) |
| 4.2 | Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.2 to Form 8-K filed June 18, 2025) |
| 4.3 | Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.2 to Form 8-K filed June 18, 2025) |
| 10.1 | Binding Term Sheet by and between Processa Pharmaceuticals and Intact Therapeutics (incorporated by reference to Exhibit 10.1 to Form 8-K filed June 17, 2025) |
| 10.2 | Form of Securities Purchase Agreement, dated June 17, 2025, by and between Processa Pharmaceuticals, Inc. and each of the Purchasers (as defined therein) (incorporated by reference to Exhibit 10.1 to Form 8-K filed June 18, 2025) |
| 10.3 | Amendment No. 1 to License Agreement with Yuhan Corporation (incorporated by reference to Exhibit 10.1 to Form 8-K filed June 30, 2025) |
| 10.4 | Termination of Licensing Agreement dated June 27, 2025 (incorporated by reference to Exhibit 10.1 to Form 8-K filed July 1, 2025) |
| 10.5 | Form of Securities Purchase Agreement, dated August 4, 2025, by and between Processa Pharmaceuticals, Inc. and the Purchaser (as defined therein) (incorporated by reference to Exhibit 10.1 to Form 8-K filed August 7, 2025) |
| 31.1* | Rule 153-14(a) Certification by Principal Executive Officer |
| 31.2* | Rule 153-14(a) Certification by Principal Financial Officer |
| 32.1*++ | Section 1350 Certification of Principal Executive Officer and Principal Financial Officer |
| 99.1 | XBRL Files |
| 101.INS | Inline XBRL Instance Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
- Filed herewith.
++ This certification is being furnished solely to accompany this Quarterly Report pursuant to 18 U.S.C. Section 1350 and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.